Clinical Trials Browser

Recruiting × balstilimab × Sarcoma × Clear all

NCT04028063 2026-01-27

Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas

Phase 2 Recruiting

Sarcoma